An expert discusses treatments for narcolepsy, comparing options for managing excessive daytime sleepiness (EDS) and cataplexy, and examines the advantages, limitations, and clinical scenarios for ...

People who live with narcolepsy — about one out of every 2,000 Americans — don’t have many options when it comes to treatment. The milder form of narcolepsy includes symptoms of excessive ...

An expert discusses the significance of low-sodium oxybate for patients with narcolepsy patients with and cardiovascular disease and compares the diagnostic criteria and clinical presentations of ...

Medically reviewed by Daniel Combs, MD More than 50 million Americans have a sleep disorder. Regularly having trouble ...

The main growth driver for Alkermes going forward will be ALKS 2680. Read why I maintain my buy rating on ALKS stock.

The Federal Motor Carrier Safety Administration recommends disqualifying individuals with a narcolepsy diagnosis, regardless of treatment. According to 2022 statistics, narcolepsy may put you at a ...

Adderall is FDA approved to treat narcolepsy in children ages 6 years and older. Adderall and Adderall XR are also FDA approved to treat ADHD in children: Adderall is approved for children ages 3 ...

The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and ...

The Pennsylvania-based drugmaker expects between $820 million and $860 million this year from WAKIX, as it pushes its ...

"We’re delighted to welcome Kevin to Avadel – he’s a great addition to our team with the deep experience to help us drive success at this important time," said Greg Divis, Chief Executive Officer of ...

The company has announced significant progress in its preclinical studies of Dual Orexin Receptor Agonists (DOXAs), specifically AEX-41 and AEX-2, which are being developed to treat narcolepsy and ...